Peer-reviewed veterinary case report
Using blood test NT-proBNP to detect heart disease in dogs
By Oyama, Mark A et al.·Published in Journal of the American Veterinary Medical Association·2008·Department of Veterinary Clinical Studies-Philadelphia, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity.
- Species:
- dog
Plain-English summary
A study found that measuring a specific blood marker called NT-proBNP can help identify heart problems in dogs, especially those with mitral valve disease or dilated cardiomyopathy. Dogs with heart disease had much higher levels of this marker compared to healthy dogs, and a level above 445 pmol/L was effective in distinguishing between the two groups. This test can also provide insights into the severity of the heart condition and help assess related issues like heart size and breathing rate. Overall, NT-proBNP testing could be a valuable tool for veterinarians in diagnosing and managing heart disease in dogs.
People also search for: dog heart disease symptoms · NT-proBNP test for dogs · how to tell if my dog has heart problems
Abstract
OBJECTIVE: To determine whether serum N-terminal pro-B-type natriuretic (NT-proBNP) concentration could be used to identify cardiac disease in dogs and to assess disease severity in affected dogs. DESIGN: Cross-sectional study. ANIMALS: 119 dogs with mitral valve disease, 18 dogs with dilated cardiomyopathy, and 40 healthy control dogs. PROCEDURES: Serum NT-proBNP concentration was measured with an ELISA validated for use in dogs. Results of physical examination, thoracic radiography, echocardiography, and serum biochemical analyses were recorded for dogs with cardiac disease. RESULTS: Serum NT-proBNP concentration was significantly higher in dogs with cardiac disease than in control dogs, and a serum NT-proBNP concentration > 445 pmol/L could be used to discriminate dogs with cardiac disease from control dogs with a sensitivity of 83.2% and specificity of 90.0%. In dogs with cardiac disease, serum NT-proBNP concentration was correlated with heart rate, respiratory rate, echocardiographic heart size, and renal function. For dogs with cardiac disease, serum NT-proBNP concentration could be used to discriminate dogs with and without radiographic evidence of cardiomegaly and dogs with and without congestive heart failure. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggested that serum NT-proBNP concentration may be a useful adjunct clinical test for diagnosing cardiac disease in dogs and assessing the severity of disease in dogs with cardiac disease.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/18479239/